Allergy Therapeutics Plc (AGY) Ord GBP0.01
0.30p
(4.41%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.30p
(4.41%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.30p
(4.41%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
6.80p
7.00p
7.70p
£309.82 million
6.80p
6.33p
2.55p
n/a
0.30p (4.62%) Previous:
0.30p
49,350
n/a
150,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 30/06/2024 | 30/06/2023 |
|---|---|---|
| Revenue (£m) | 55.20 | 59.59 |
| Profit before tax (£m) | (39.17) | (41.77) |
| Adjusted EPS (p): | (1.07) | (6.43) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Important Documents
There are no documents available for this stock.
-
Allergy Therapeutics starts dosing peanut allergy vaccine candidate
27 March 2023 15:16
-
Allergy Therapeutics confident in funding as results remain late
20 January 2023 12:33
-
Allergy Therapeutics pauses production at Freeman facility
4 October 2022 14:10
-
New Executive Long Term Incentive Awards
3 March 2025 07:00
-
Presentations at 2025 AAAAI / WAO Joint Congress
27 February 2025 07:00
-
Grass MATA MPL Phase III data published in Allergy
17 February 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.